What's Going On With Tilray Brands Stock On Thursday?
Tilray's Expansion in Europe: Tilray Brands, Inc. is expanding its medical cannabis presence in Europe by launching its Good Supply brand in Germany, offering a range of affordable and high-quality cannabis flower products to meet the evolving needs of patients and providers.
Stock Performance: Despite a significant decline of over 76% in TLRY stock over the past year, shares rose by 3.5% to $0.45 following the announcement of the new product launch.
Trade with 70% Backtested Accuracy
Analyst Views on YOLO
About the author
Unusual Volume Alert: YOLO ETF on Wednesday
ETF Performance: The ETF with the highest volume on Wednesday featured Canopy Growth, which rose approximately 7.9% with over 76.6 million shares traded, while Tilray Brands fell about 6.7% with over 21.9 million shares exchanged.
Market Activity: The trading session highlighted significant movements in the cannabis sector, particularly with the notable volume of shares for both Canopy Growth and Tilray Brands.
Video Feature: A video segment titled "Wednesday's ETF with Unusual Volume: YOLO" was mentioned, indicating a focus on the ETF's performance.
Author's Disclaimer: The opinions expressed in the article are those of the author and do not necessarily represent the views of Nasdaq, Inc.
Canopy Growth Set to Purchase MTL Cannabis
Acquisition Details: Canopy Growth Corporation has agreed to acquire MTL Cannabis Corp. for approximately 125 million Canadian dollars in a cash-and-stock deal, with MTL shareholders receiving shares and cash for their holdings.
Strategic Benefits: The acquisition is expected to enhance Canopy's position in Canada's medical cannabis market, expanding its patient network and improving access to high-quality flower supply, particularly in Québec.
Financial Performance: MTL reported net revenue of 84 million Canadian dollars and a gross margin of 51% as of September 30, 2025, while Canopy anticipates annualized cost synergies of about 10 million Canadian dollars within 18 months.
Management Changes: Following the acquisition, MTL's leadership team will join Canopy Growth, with MTL CEO Michael Perron becoming the Chief Operating Officer, indicating a strategic integration of both companies' operations.
Cannabis ETFs Surge by Double Digits on Friday: Find Out the Reasons
Cannabis Stock Surge: On December 12, 2025, cannabis stocks experienced a significant surge, with the Amplify Seymour Cannabis ETF rising over 54% due to reports of President Trump's plans to reclassify marijuana from Schedule I to Schedule III, which could ease federal regulations and encourage investment.
Potential Reclassification Impact: The reclassification would allow cannabis companies to benefit from different tax regulations and potentially increase pharmaceutical acceptance, although uncertainties remain regarding the final policy confirmation.
Market Reactions: Other cannabis ETFs also saw substantial gains on the same day, including Roundhill Cannabis ETF (up 55.7%) and Advisorshares Pure US Cannabis ETF (up 54.3%), reflecting heightened investor optimism in the sector.
Long-term Industry Outlook: Despite recent gains, the cannabis industry has faced challenges, with stocks like Tilray down significantly over the past five years; however, the current political climate under Trump's second term appears to be more favorable for the industry.
Trump's Cannabis Rescheduling Executive Order Anticipated on Monday, According to CNBC
Trump's Executive Order: President Donald Trump is expected to sign an executive order on Monday to reclassify marijuana as a less dangerous drug, moving it from Schedule I to Schedule III of the Controlled Substances Act.
Market Reaction: Cannabis stocks, including major Canadian Licensed Producers and U.S. multi-state operators, have seen significant gains in response to the news, with AdvisorShares Pure Cannabis ETF experiencing its largest intraday rally on record.
Impact on Cannabis Companies: The reclassification is anticipated to provide cannabis companies with tax breaks and fewer restrictions for product transfers across state lines, although it will not lead to federal legalization for recreational use.
Notable Gainers: Companies such as Canopy Growth, Tilray, and Curaleaf, among others, have been highlighted as notable gainers in the cannabis market following the announcement of the potential executive order.
Germany restricts online cannabis sales amid rising import levels.
New Cannabis Regulations in Germany: The German government has announced new measures to limit online cannabis sales following a rise in imports since the legalization of recreational use last year.
Prescription and Delivery Changes: Patients will now be required to meet with a doctor in person to obtain cannabis prescriptions, and mail-order deliveries will be banned, with cannabis only available at physical pharmacies for proper guidance.
Unusual Volume Alert: YOLO ETF on Monday
ETF Performance: The ETF with the highest volume on Monday included Tilray Brands, which saw a decline of about 3.4% with over 76.4 million shares traded, and Canopy Growth, which increased by approximately 1.9% on a volume of over 12.7 million shares.
Top Performer: Village Farms International was the best-performing component of the ETF on Monday, rising by about 14.8%.
Unusual Volume Alert: YOLO ETF on Wednesday
ETF Performance: The ETF with the highest volume on Wednesday featured Canopy Growth, which rose approximately 7.9% with over 76.6 million shares traded, while Tilray Brands fell about 6.7% with over 21.9 million shares exchanged.
Market Activity: The trading session highlighted significant movements in the cannabis sector, particularly with the notable volume of shares for both Canopy Growth and Tilray Brands.
Video Feature: A video segment titled "Wednesday's ETF with Unusual Volume: YOLO" was mentioned, indicating a focus on the ETF's performance.
Author's Disclaimer: The opinions expressed in the article are those of the author and do not necessarily represent the views of Nasdaq, Inc.
Canopy Growth Set to Purchase MTL Cannabis
Acquisition Details: Canopy Growth Corporation has agreed to acquire MTL Cannabis Corp. for approximately 125 million Canadian dollars in a cash-and-stock deal, with MTL shareholders receiving shares and cash for their holdings.
Strategic Benefits: The acquisition is expected to enhance Canopy's position in Canada's medical cannabis market, expanding its patient network and improving access to high-quality flower supply, particularly in Québec.
Financial Performance: MTL reported net revenue of 84 million Canadian dollars and a gross margin of 51% as of September 30, 2025, while Canopy anticipates annualized cost synergies of about 10 million Canadian dollars within 18 months.
Management Changes: Following the acquisition, MTL's leadership team will join Canopy Growth, with MTL CEO Michael Perron becoming the Chief Operating Officer, indicating a strategic integration of both companies' operations.
Cannabis ETFs Surge by Double Digits on Friday: Find Out the Reasons
Cannabis Stock Surge: On December 12, 2025, cannabis stocks experienced a significant surge, with the Amplify Seymour Cannabis ETF rising over 54% due to reports of President Trump's plans to reclassify marijuana from Schedule I to Schedule III, which could ease federal regulations and encourage investment.
Potential Reclassification Impact: The reclassification would allow cannabis companies to benefit from different tax regulations and potentially increase pharmaceutical acceptance, although uncertainties remain regarding the final policy confirmation.
Market Reactions: Other cannabis ETFs also saw substantial gains on the same day, including Roundhill Cannabis ETF (up 55.7%) and Advisorshares Pure US Cannabis ETF (up 54.3%), reflecting heightened investor optimism in the sector.
Long-term Industry Outlook: Despite recent gains, the cannabis industry has faced challenges, with stocks like Tilray down significantly over the past five years; however, the current political climate under Trump's second term appears to be more favorable for the industry.
Trump's Cannabis Rescheduling Executive Order Anticipated on Monday, According to CNBC
Trump's Executive Order: President Donald Trump is expected to sign an executive order on Monday to reclassify marijuana as a less dangerous drug, moving it from Schedule I to Schedule III of the Controlled Substances Act.
Market Reaction: Cannabis stocks, including major Canadian Licensed Producers and U.S. multi-state operators, have seen significant gains in response to the news, with AdvisorShares Pure Cannabis ETF experiencing its largest intraday rally on record.
Impact on Cannabis Companies: The reclassification is anticipated to provide cannabis companies with tax breaks and fewer restrictions for product transfers across state lines, although it will not lead to federal legalization for recreational use.
Notable Gainers: Companies such as Canopy Growth, Tilray, and Curaleaf, among others, have been highlighted as notable gainers in the cannabis market following the announcement of the potential executive order.
Germany restricts online cannabis sales amid rising import levels.
New Cannabis Regulations in Germany: The German government has announced new measures to limit online cannabis sales following a rise in imports since the legalization of recreational use last year.
Prescription and Delivery Changes: Patients will now be required to meet with a doctor in person to obtain cannabis prescriptions, and mail-order deliveries will be banned, with cannabis only available at physical pharmacies for proper guidance.
Unusual Volume Alert: YOLO ETF on Monday
ETF Performance: The ETF with the highest volume on Monday included Tilray Brands, which saw a decline of about 3.4% with over 76.4 million shares traded, and Canopy Growth, which increased by approximately 1.9% on a volume of over 12.7 million shares.
Top Performer: Village Farms International was the best-performing component of the ETF on Monday, rising by about 14.8%.
